Misstatements in an Offering Memorandum: Investor Remedies

What an offering memorandum is, legally

A private placement memorandum, confidential information memorandum or offering circular is the disclosure document for a sale of securities that is exempt from registration, usually under Rule 506 of Regulation D. It describes the business, the people, the use of proceeds, the terms and the risks. The law treats every statement in it as a statement made to sell a security. It does not matter that the document is labeled confidential, that it was delivered privately or that the deal was exempt from registration: the antifraud rules apply to exempt offerings, and Government Code section 4008.052 says so expressly.

The three claims and what each requires

The Texas claim is the one most private-placement investors lead with. The guide on the Texas Securities Act covers its mechanics and defenses, and the guide on Rule 10b-5 covers the federal claim's elements and pleading burden.

Why the federal prospectus statute does not help

Section 12(a)(2) of the Securities Act, 15 U.S.C. § 77l(a)(2), looks like the perfect fit: it makes a seller liable for a material misstatement in a prospectus or oral communication without proof of intent, with rescission as the remedy. But in Gustafson v. Alloyd Co. (1995) the Supreme Court held that "prospectus" in that section means a document used in a public offering, so section 12(a)(2) does not apply to a private contract of sale. A private placement memorandum in a Rule 506 offering is not a prospectus for this purpose, and the claim fails. Investors in registered public offerings keep sections 11 and 12(a)(2); private-placement investors rely on the Texas Securities Act for the no-intent claim and on Rule 10b-5 and common law for the rest.

What counts as material

A fact is material if a reasonable investor would consider it important in deciding whether to invest. In offering memoranda, the misstatements that produce cases cluster:

• Financial statements and track record. Revenue, profitability, the performance of prior funds or projects, occupancy, production. Overstated past results are the clearest case.
• Use of proceeds. Money described as going into the business that went to the sponsor, to earlier investors or to unrelated ventures.
• The people. Omitted regulatory history, prior bankruptcies, litigation or criminal matters of the principals, and claimed credentials or experience that did not exist.
• Contracts and customers. "Signed" agreements that were letters of intent or discussions, and customer or tenant commitments that were not binding.
• Capital structure. Undisclosed debt, liens, preferred classes or side arrangements with other investors.
• Projections. Forecasts are opinions, not facts, and are actionable mainly when they had no reasonable basis, contradicted what the sponsor knew, or were presented as current results.

Omissions matter as much as statements. A memorandum that recites the business plan but does not mention that the sponsor's last two projects defaulted has omitted a fact necessary to make what it did say not misleading.

Example

Suppose a Dallas investor commits $500,000 to a self-storage development fund after a memorandum states that the sponsor's "four prior funds returned an average of 14 percent annually to investors" and that "all land for Phase I is under contract." Two of the four prior funds lost money and one land parcel was only under a letter of intent that later lapsed. Under section 4008.052 the investor tenders her interest and claims the $500,000 with interest, less distributions, against the fund's general partner as seller and against its two principals as control persons, who must prove they could not have known the truth about their own funds. Under Rule 10b-5 she pleads the same facts but must show the principals knew, which the fund's own records establish. The non-reliance clause in her subscription agreement, which says she relied on no statement outside the memorandum, does not help the sponsor, because the false statements were inside the memorandum.

The seller's defenses

Reliance disclaimers and non-reliance clauses

Subscription agreements routinely state that the investor relied only on the memorandum and made an independent investigation. Texas courts enforce a clear and specific disclaimer of reliance between sophisticated parties who negotiated at arm's length with counsel, and such a clause can defeat a fraud claim based on statements outside the document. Boilerplate in a form agreement, or a disclaimer that the investor had no real chance to negotiate, carries less weight, and no disclaimer protects misstatements inside the very document the investor is told to rely on. Under the Texas Securities Act reliance is not an element, so the disclaimer does not defeat the statutory claim; the seller must instead prove the buyer actually knew the truth. Federal courts treat non-reliance clauses as strong evidence against reliance in a Rule 10b-5 claim between sophisticated parties, with the same limit for misstatements within the offering document itself. "Big boy" letters, in which a sophisticated buyer acknowledges the seller may have material information it has not shared, raise the same questions and are enforced to the same degree.

Accredited investor status

Being accredited is a condition of the Rule 506 exemption, not a license to be lied to. It is not a defense to a Texas Securities Act claim or to fraud. It becomes relevant to justifiable reliance under the common law and to the reasonableness of the investor's own diligence, which is why sellers raise it. A sophisticated investor who had access to the real financial statements and did not read them may have a reliance problem on a common-law claim; the same investor keeps the statutory claim unless the seller proves actual knowledge.

Risk factors and cautionary language

A memorandum's risk-factor section warns that the business may fail. It does not cure a false statement of present fact: a warning that "projections may not be achieved" does not excuse a misstated track record or an invented contract. Risk factors matter most when the claim is about optimistic projections, where specific, meaningful warnings can make the forecast non-actionable.

The other defenses

Reasonable care under section 4008.052(c), which the seller must prove and which an issuer cannot invoke for its own offering documents; the buyer's actual knowledge of the truth; a compliant rescission offer that the buyer failed to reject in writing within 30 days; and limitations. The guide on securities deadlines dates each period.

Evidence that decides these cases

• The memorandum and every supplement, with the version you received and the date.
• The subscription agreement and investor questionnaire, for the representations and any non-reliance language.
• Decks, emails, webinar recordings and texts from the sponsor and the salesman, which are statements too and often less careful than the memorandum.
• Investor updates after closing, which show when the truth emerged and start the discovery clock.
• The sponsor's records of the facts misstated: prior fund results, bank records for use of proceeds, the actual contracts. These come in discovery and are the reason sellers settle.

For sponsors and issuers

A company that finds an error in its own memorandum has a short window to correct it. A supplement delivered before closing cures the problem for investors who have not yet bought. For those who have, a compliant rescission offer under the Texas Securities Act can cap the exposure, and candor with investors now is cheaper than the same facts emerging in discovery later. The guide on defending an investor lawsuit picks up from there.

When to involve a litigator

When a fact in the memorandum turns out to be wrong, not when the investment fails. The two are different events, and only the first is a claim. A litigator can compare the memorandum against what you have since learned, identify the seller and control persons, date the three clocks and tell you whether rescission or damages is the better path. Tina Wysk represents investors and issuers in securities and investment disputes in Dallas state and federal courts.